{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "Natriuretic Peptide Receptor type C (NPR-C)", "SARS-COV-2", "SARS-COV-2 infection", "chronic thromboembolic pulmonary hypertension", "pulmonary arterial hypertension", "vascular disease"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36601347", "DateRevised": {"Year": "2023", "Month": "03", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "19"}], "Language": ["eng"], "ELocationID": ["1023758", "10.3389/fphys.2022.1023758"], "Journal": {"ISSN": "1664-042X", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in physiology", "ISOAbbreviation": "Front Physiol"}, "ArticleTitle": "From acute SARS-CoV-2 infection to pulmonary hypertension.", "Pagination": {"StartPage": "1023758", "MedlinePgn": "1023758"}, "Abstract": {"AbstractText": ["As the world progressively recovers from the acute stages of the coronavirus disease 2019 (COVID-19) pandemic, we may be facing new challenges regarding the long-term consequences of COVID-19. Accumulating evidence suggests that pulmonary vascular thickening may be specifically associated with COVID-19, implying a potential tropism of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) virus for the pulmonary vasculature. Genetic alterations that may influence the severity of COVID-19 are similar to genetic drivers of pulmonary arterial hypertension. The pathobiology of the COVID-19-induced pulmonary vasculopathy shares many features (such as medial hypertrophy and smooth muscle cell proliferation) with that of pulmonary arterial hypertension. In addition, the presence of microthrombi in the lung vessels of individuals with COVID-19 during the acute phase, may predispose these subjects to the development of chronic thromboembolic pulmonary hypertension. These similarities raise the intriguing question of whether pulmonary hypertension (PH) may be a long-term sequela of SARS-COV-2 infection. Accumulating evidence indeed support the notion that SARS-COV-2 infection is indeed a risk factor for persistent pulmonary vascular defects and subsequent PH development, and this could become a major public health issue in the future given the large number of individuals infected by SARS-COV-2 worldwide. Long-term studies assessing the risk of developing chronic pulmonary vascular lesions following COVID-19 infection is of great interest for both basic and clinical research and may inform on the best long-term management of survivors."], "CopyrightInformation": "Copyright \u00a9 2022 Eroume \u00c0 Egom, Shiwani and Nouthe."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institut du Savoir Montfort (ISM), University of Ottawa, Ottawa, ON, Canada."}, {"Identifier": [], "Affiliation": "CIEL, Centre d'Innovation et de Commercialisation en Recherche Clinique et Bio-M\u00e9dicale Imm\u00e2now'EL, B\u00e9atitude/Nkolbisson, Yaound\u00e9, Cameroon."}, {"Identifier": [], "Affiliation": "Laboratory of Endocrinology and Radioisotopes, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaound\u00e9, Cameroon."}], "LastName": "Eroume \u00c0 Egom", "ForeName": "Emmanuel", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Burnley General Hospital, East Lancashire Hospitals NHS Trust, Burnley, United Kingdom."}], "LastName": "Shiwani", "ForeName": "Haaris A", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, The University of British Columbia, Vancouver, BC, Canada."}], "LastName": "Nouthe", "ForeName": "Brice", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Physiol", "NlmUniqueID": "101549006", "ISSNLinking": "1664-042X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abraham G. R., Kuc R. E., Althage M., Greasley P. J., Ambery P., Maguire J. J., et al. (2022). Endothelin-1 is increased in the plasma of patients hospitalised with Covid-19. J. Mol. Cell. Cardiol. 167, 92\u201396. 10.1016/j.yjmcc.2022.03.007", "ArticleIdList": ["10.1016/j.yjmcc.2022.03.007", "PMC8941861", "35339512"]}, {"Citation": "Ackermann M., Mentzer S. J., Kolb M., Jonigk D. (2020a). Inflammation and intussusceptive angiogenesis in COVID-19: Everything in and out of flow. Eur. Respir. J. 56, 2003147. 10.1183/13993003.03147-2020", "ArticleIdList": ["10.1183/13993003.03147-2020", "PMC7530910", "33008942"]}, {"Citation": "Ackermann M., Verleden S. E., Kuehnel M., Haverich A., Welte T., Laenger F., et al. (2020b). Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. N. Engl. J. Med. 383, 120\u2013128. 10.1056/NEJMoa2015432", "ArticleIdList": ["10.1056/NEJMoa2015432", "PMC7412750", "32437596"]}, {"Citation": "Algadeeb K. B., AlMousa H. H., AlKadhem S. M., Alduhilan M. O., Almatawah Y. (2020). A novel case of severe respiratory symptoms and persistent pulmonary hypertension in a Saudi neonate with SARS-CoV-2 infection. Cureus 12, e10472. 10.7759/cureus.10472", "ArticleIdList": ["10.7759/cureus.10472", "PMC7566984", "33083174"]}, {"Citation": "Ataei M., Shirazi F. M., Lamarine R. J., Nakhaee S., Mehrpour O. (2020). A double-edged sword of using opioids and COVID-19: A toxicological view. Subst. Abuse Treat. Prev. Policy 15, 91. 10.1186/s13011-020-00333-y", "ArticleIdList": ["10.1186/s13011-020-00333-y", "PMC7711252", "33272308"]}, {"Citation": "Benza R. L., Miller D. P., Frost A., Barst R. J., Krichman A. M., McGoon M. D. (2010). Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry. Transplantation 90, 298\u2013305. 10.1097/TP.0b013e3181e49b83", "ArticleIdList": ["10.1097/TP.0b013e3181e49b83", "20559158"]}, {"Citation": "Berger J. S., Kunichoff D., Adhikari S., Ahuja T., Amoroso N., Aphinyanaphongs Y., et al. (2020). Prevalence and outcomes of D-dimer elevation in hospitalized patients with COVID-19. Arterioscler. Thromb. Vasc. Biol. 40, 2539\u20132547. 10.1161/ATVBAHA.120.314872", "ArticleIdList": ["10.1161/ATVBAHA.120.314872", "PMC7505147", "32840379"]}, {"Citation": "Birnhuber A., Flie\u00dfer E., Gorkiewicz G., Zacharias M., Seeliger B., David S., et al. (2021). Between inflammation and thrombosis: Endothelial cells in COVID-19. Eur. Respir. J. 58, 2100377. 10.1183/13993003.00377-2021", "ArticleIdList": ["10.1183/13993003.00377-2021", "PMC8112008", "33958433"]}, {"Citation": "Borczuk A. C., Salvatore S. P., Seshan S. v., Patel S. S., Bussel J. B., Mostyka M., et al. (2020). COVID-19 pulmonary pathology: A multi-institutional autopsy cohort from Italy and New York city. Mod. Pathol. 33, 2156\u20132168. 10.1038/s41379-020-00661-1", "ArticleIdList": ["10.1038/s41379-020-00661-1", "PMC7463226", "32879413"]}, {"Citation": "Butrous G. (2015). Human immunodeficiency virus-associated pulmonary arterial hypertension: Considerations for pulmonary vascular diseases in the developing world. Circulation 131, 1361\u20131370. 10.1161/CIRCULATIONAHA.114.006978", "ArticleIdList": ["10.1161/CIRCULATIONAHA.114.006978", "25869003"]}, {"Citation": "Butrous G. (2020). Pulmonary hypertension: From an orphan disease to a global epidemic. Glob. Cardiol. Sci. Pract. 2020, e202005. 10.21542/gcsp.2020.5", "ArticleIdList": ["10.21542/gcsp.2020.5", "PMC7590934", "33150150"]}, {"Citation": "Cao Y., Hiyoshi A., Montgomery S. (2020). COVID-19 case-fatality rate and demographic and socioeconomic influencers: Worldwide spatial regression analysis based on country-level data. BMJ Open 10, e043560. 10.1136/bmjopen-2020-043560", "ArticleIdList": ["10.1136/bmjopen-2020-043560", "PMC7640588", "33148769"]}, {"Citation": "Carvelli J., Demaria O., V\u00e9ly F., Batista L., Chouaki Benmansour N., Fares J., et al. (2020). Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. Nature 588, 146\u2013150. 10.1038/s41586-020-2600-6", "ArticleIdList": ["10.1038/s41586-020-2600-6", "PMC7116884", "32726800"]}, {"Citation": "Chin K. M., Channick R. N., Rubin L. J. (2006). Is methamphetamine use associated with idiopathic pulmonary arterial hypertension? Chest 130, 1657\u20131663. 10.1378/chest.130.6.1657", "ArticleIdList": ["10.1378/chest.130.6.1657", "17166979"]}, {"Citation": "Cueto-Robledo G., Porres-Aguilar M., Puebla-Aldama D., Barrag\u00e1n-Mart\u00ednez M. D. P., Jurado-Hern\u00e1ndez M. Y., Garc\u00eda-C\u00e9sar M., et al. (2022). Severe pulmonary hypertension: An important sequel after severe post-acute COVID-19 pneumonia. Curr. Probl. Cardiol. 47, 101004. 10.1016/j.cpcardiol.2021.101004", "ArticleIdList": ["10.1016/j.cpcardiol.2021.101004", "PMC8482545", "34601005"]}, {"Citation": "D\u2019Alonzo G. E., Barst R. J., Ayres S. M., Bergofsky E. H., Brundage B. H., Detre K. M., et al. (1991). Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann. Intern. Med. 115, 343\u2013349. 10.7326/0003-4819-115-5-343", "ArticleIdList": ["10.7326/0003-4819-115-5-343", "1863023"]}, {"Citation": "\nDalvi P., O\u2019Brien-Ladner A., Dhillon N. (2018). Differential expression of MicroRNAs during cocaine and HIV-tat mediated enhanced proliferation of pulmonary smooth muscle cells: Probable involvement in the regulation of bone morphogenetic protein receptor expression. Am J Respir Crit Care Med 189Available at: https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A1206 (Accessed May 22, 2022).", "ArticleIdList": ["10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A1206"]}, {"Citation": "de Oliveira N\u00f3brega C. G., do Nascimento W. R. C., Santos P., d\u2019Emery A., de Lorena V. M. B., Medeiros D., et al. (2021). Schistosoma mansoni infection is associated with decreased risk of respiratory allergy symptoms and low production of CCL2. Trop. Med. Int. Health. 26, 1098\u20131109. 10.1111/tmi.13639", "ArticleIdList": ["10.1111/tmi.13639", "34107115"]}, {"Citation": "Delorey T. M., Ziegler C. G. K., Heimberg G., Normand R., Yang Y., Segerstolpe \u00c5., et al. (2021). COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595, 107\u2013113. 10.1038/s41586-021-03570-8", "ArticleIdList": ["10.1038/s41586-021-03570-8", "PMC8919505", "33915569"]}, {"Citation": "Dhillon N. K., Li F., Xue B., Tawfik O., Morgello S., Buch S., et al. (2011). Effect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction. Am. J. Respir. Cell. Mol. Biol. 45, 40\u201352. 10.1165/rcmb.2010-0097OC", "ArticleIdList": ["10.1165/rcmb.2010-0097OC", "PMC3145070", "20802087"]}, {"Citation": "Dub\u00e9 M. P., Lema\u00e7on A., Barhdadi A., Lemieux Perreault L. P., Oussa\u00efd E., Asselin G., et al. (2021). Genetics of symptom remission in outpatients with COVID-19. Sci. Rep. 11, 10847. 10.1038/S41598-021-90365-6", "ArticleIdList": ["10.1038/S41598-021-90365-6", "PMC8149390", "34035401"]}, {"Citation": "Egom E. E. A., Moyou-Somo R., Oyono J. L. E., Kamgang R. (2021). Identifying potential mutations responsible for cases of pulmonary arterial hypertension. Appl. Clin. Genet. 14, 113\u2013124. 10.2147/TACG.S260755", "ArticleIdList": ["10.2147/TACG.S260755", "PMC7958998", "33732008"]}, {"Citation": "Egom E. E., Feridooni T., Pharithi R. B., Khan B., Shiwani H. A., Maher V., et al. (2017a). A natriuretic peptides clearance receptor\u2019s agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure. Biomed. Pharmacother. 93, 1144\u20131150. 10.1016/j.biopha.2017.07.027", "ArticleIdList": ["10.1016/j.biopha.2017.07.027", "28738523"]}, {"Citation": "Egom E. E., Feridooni T., Pharithi R. B., Khan B., Shiwani H. A., Maher V., et al. (2017b). New insights and new hope for pulmonary arterial hypertension: Natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease. Int. J. Physiol. Pathophysiol. Pharmacol. 9, 112\u2013118. 10.1016/s0735-1097(17)35291-9", "ArticleIdList": ["10.1016/s0735-1097(17)35291-9", "PMC5592245", "28951773"]}, {"Citation": "Farr R. J., Rootes C. L., Rowntree L. C., Nguyen T. H. O., Hensen L., Kedzierski L., et al. (2021). Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection. PLoS Pathog. 17, e1009759. 10.1371/journal.ppat.1009759", "ArticleIdList": ["10.1371/journal.ppat.1009759", "PMC8318295", "34320031"]}, {"Citation": "Firth A. L., Yao W., Ogawa A., Madani M. M., Lin G. Y., Yuan J. X.-J. (2010). Multipotent mesenchymal progenitor cells are present in endarterectomized tissues from patients with chronic thromboembolic pulmonary hypertension. Am. J. Physiol. Cell. Physiol. 298, C1217\u2013C1225. 10.1152/ajpcell.00416.2009", "ArticleIdList": ["10.1152/ajpcell.00416.2009", "PMC2867379", "20181931"]}, {"Citation": "Gali\u00e8 N., Humbert M., Vachiery J.-L., Gibbs S., Lang I., Torbicki A., et al. (2016). 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS): Endorsed by: Association for European paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT). Eur. Heart J. 37, 67\u2013119. 10.1093/eurheartj/ehv317", "ArticleIdList": ["10.1093/eurheartj/ehv317", "26320113"]}, {"Citation": "Garcia J. G., Patterson C., Bahler C., Aschner J., Hart C. M., English D. (1993). Thrombin receptor activating peptides induce Ca2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet-derived growth factor mRNA expression in cultured endothelium. J. Cell. Physiol. 156, 541\u2013549. 10.1002/jcp.1041560313", "ArticleIdList": ["10.1002/jcp.1041560313", "8360259"]}, {"Citation": "Goel S., Saheb Sharif-Askari F., Saheb Sharif Askari N., Madkhana B., Alwaa A. M., Mahboub B., et al. (2021). SARS-CoV-2 switches \u201con\u201d MAPK and NF\u03baB signaling via the reduction of nuclear DUSP1 and DUSP5 expression. Front. Pharmacol. 12, 631879. 10.3389/fphar.2021.631879", "ArticleIdList": ["10.3389/fphar.2021.631879", "PMC8114414", "33995033"]}, {"Citation": "Grimes J. M., Grimes K. (2020). p38 MAPK inhibition: A promising therapeutic approach for COVID-19. J. Mol. Cell. Cardiol. 144, 63\u201365. 10.1016/j.yjmcc.2020.05.007", "ArticleIdList": ["10.1016/j.yjmcc.2020.05.007", "PMC7228886", "32422320"]}, {"Citation": "Haberecker M., Schwarz E. I., Steiger P., Frontzek K., Scholkmann F., Zeng X., et al. (2022). Autopsy-based pulmonary and vascular pathology: Pulmonary endotheliitis and multi-organ involvement in COVID-19 associated deaths. Respiration. 101, 155\u2013165. 10.1159/000518914", "ArticleIdList": ["10.1159/000518914", "PMC8678227", "34525475"]}, {"Citation": "Halawa S., Pullamsetti S. S., Bangham C. R. M., Stenmark K. R., Dorfm\u00fcller P., Frid M. G., et al. (2022). Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: A global perspective. Nat. Rev. Cardiol. 19, 314\u2013331. 10.1038/s41569-021-00640-2", "ArticleIdList": ["10.1038/s41569-021-00640-2", "PMC8647069", "34873286"]}, {"Citation": "Hamming I., Timens W., Bulthuis M. L. C., Lely A. T., Navis G. J., van Goor H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631\u2013637. 10.1002/path.1570", "ArticleIdList": ["10.1002/path.1570", "PMC7167720", "15141377"]}, {"Citation": "Hannemann J., Balfanz P., Schwedhelm E., Hartmann B., Ule J., M\u00fcller-Wieland D., et al. (2021). Elevated serum SDMA and ADMA at hospital admission predict in-hospital mortality of COVID-19 patients. Sci. Rep. 11, 9895. 10.1038/s41598-021-89180-w", "ArticleIdList": ["10.1038/s41598-021-89180-w", "PMC8110746", "33972591"]}, {"Citation": "Hobohm L., Sagoschen I., Barco S., Schmidtmann I., Espinola-Klein C., Konstantinides S., et al. (2022). Trends and risk factors of in-hospital mortality of patients with COVID-19 in Germany: Results of a large nationwide inpatient sample. Viruses 14, 275. 10.3390/v14020275", "ArticleIdList": ["10.3390/v14020275", "PMC8880622", "35215869"]}, {"Citation": "Honardoost M., Janani L., Aghili R., Emami Z., Khamseh M. E. (2021). The association between presence of comorbidities and COVID-19 severity: A systematic review and meta-analysis. Cerebrovasc. Dis. 50, 132\u2013140. 10.1159/000513288", "ArticleIdList": ["10.1159/000513288", "PMC7900456", "33530081"]}, {"Citation": "Humbert M., Guignabert C., Bonnet S., Dorfm\u00fcller P., Klinger J. R., Nicolls M. R., et al. (2019). Pathology and pathobiology of pulmonary hypertension: State of the art and research perspectives. Eur. Respir. J. 53, 1801887. 10.1183/13993003.01887-2018", "ArticleIdList": ["10.1183/13993003.01887-2018", "PMC6351340", "30545970"]}, {"Citation": "Humbert M., Sitbon O., Ya\u00efci A., Montani D., O\u2019Callaghan D. S., Ja\u00efs X., et al. (2010). Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur. Respir. J. 36, 549\u2013555. 10.1183/09031936.00057010", "ArticleIdList": ["10.1183/09031936.00057010", "20562126"]}, {"Citation": "Idilman I. S., Telli Dizman G., Ardali Duzgun S., Irmak I., Karcaaltincaba M., Inkaya A. C., et al. (2021). Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy. Eur. Radiol. 31, 1090\u20131099. 10.1007/s00330-020-07155-3", "ArticleIdList": ["10.1007/s00330-020-07155-3", "PMC7455509", "32860146"]}, {"Citation": "Jackson C. B., Farzan M., Chen B., Choe H. (2022). Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell. Biol. 23, 3\u201320. 10.1038/s41580-021-00418-x", "ArticleIdList": ["10.1038/s41580-021-00418-x", "PMC8491763", "34611326"]}, {"Citation": "Jahani M., Dokaneheifard S., Mansouri K. (2020). Hypoxia: A key feature of COVID-19 launching activation of HIF-1 and cytokine storm. J. Inflamm. 17, 33. 10.1186/s12950-020-00263-3", "ArticleIdList": ["10.1186/s12950-020-00263-3", "PMC7594974", "33139969"]}, {"Citation": "Jones S. A., Hunter C. A. (2021). Is IL-6 a key cytokine target for therapy in COVID-19? Nat. Rev. Immunol. 21, 337\u2013339. 10.1038/s41577-021-00553-8", "ArticleIdList": ["10.1038/s41577-021-00553-8", "PMC8043092", "33850327"]}, {"Citation": "Kanwugu O. N., Adadi P. (2021). HIV/SARS-CoV-2 coinfection: A global perspective. J. Med. Virol. 93, 726\u2013732. 10.1002/jmv.26321", "ArticleIdList": ["10.1002/jmv.26321", "PMC7404432", "32692406"]}, {"Citation": "Karmakar C. S., Hannan M. A., Islam M. S., Bhowmik D. K., Akm A. (2021). Pulmonary hypertension following severe COVID\u201319: A case report. Anaesth. Pain & Intensive Care 25, 539\u2013543. 10.35975/APICARE.V25I4.1554", "ArticleIdList": ["10.35975/APICARE.V25I4.1554"]}, {"Citation": "Kennedy A. E., Cook L., Breznik J. A., Cowbrough B., Wallace J. G., Huynh A., et al. (2021). Lasting changes to circulating leukocytes in people with mild SARS-CoV-2 infections. Viruses 13, 2239. 10.3390/v13112239", "ArticleIdList": ["10.3390/v13112239", "PMC8622816", "34835045"]}, {"Citation": "Khalil B. A., Elemam N. M., Maghazachi A. A. (2021). Chemokines and chemokine receptors during COVID-19 infection. Comput. Struct. Biotechnol. J. 19, 976\u2013988. 10.1016/j.csbj.2021.01.034", "ArticleIdList": ["10.1016/j.csbj.2021.01.034", "PMC7859556", "33558827"]}, {"Citation": "Khan A. W., Ullah I., Khan K. S., Tahir M. J., Masyeni S., Harapan H. (2021). Pulmonary arterial hypertension post COVID-19: A sequala of SARS-CoV-2 infection? Respir. Med. Case Rep. 33, 101429. 10.1016/j.rmcr.2021.101429", "ArticleIdList": ["10.1016/j.rmcr.2021.101429", "PMC8114592", "33996435"]}, {"Citation": "\nKling H., Tarantelli R., Champion H., Morris A., Gladwin M., Norris K. (2018). Chronic immune activation is associated with development of pulmonary arterial hypertension in A non-human primate model of HIV-infection. Am. J. Respir. Crit. Care Med.\n189. Available at: https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3982 (Accessed May 22, 2022).", "ArticleIdList": ["10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3982"]}, {"Citation": "Klok F. A., Kruip M. J. H. A., van der Meer N. J. M., Arbous M. S., Gommers D., Kant K. M., et al. (2020). Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb. Res. 191, 148\u2013150. 10.1016/j.thromres.2020.04.041", "ArticleIdList": ["10.1016/j.thromres.2020.04.041", "PMC7192101", "32381264"]}, {"Citation": "Kolosionek E., King J., Rollinson D., Schermuly R. T., Grimminger F., Graham B. B., et al. (2013). Schistosomiasis causes remodeling of pulmonary vessels in the lung in a heterogeneous localized manner: Detailed study. Pulm. Circ. 3, 356\u2013362. 10.4103/2045-8932.114764", "ArticleIdList": ["10.4103/2045-8932.114764", "PMC3757830", "24015336"]}, {"Citation": "Kosmaczewska A., Frydecka I. (2020). Dysregulation of the immune system as a driver of the critical course of novel coronavirus disease 2019. Pol. Arch. Intern. Med. 130, 779\u2013788. 10.20452/pamw.15482", "ArticleIdList": ["10.20452/pamw.15482", "32627515"]}, {"Citation": "Kundu R., Narean J. S., Wang L., Fenn J., Pillay T., Fernandez N. D., et al. (2022). Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts. Nat. Commun. 13, 80. 10.1038/s41467-021-27674-x", "ArticleIdList": ["10.1038/s41467-021-27674-x", "PMC8748880", "35013199"]}, {"Citation": "Lehmann A., Prosch H., Zehetmayer S., Gysan M. R., Bernitzky D., Vonbank K., et al. (2021). Impact of persistent D-dimer elevation following recovery from COVID-19. PLoS One 16, e0258351. 10.1371/journal.pone.0258351", "ArticleIdList": ["10.1371/journal.pone.0258351", "PMC8553152", "34710097"]}, {"Citation": "Lehmann M. H., Lehmann J. M., Erfle V. (2019). Nef-induced CCL2 expression contributes to HIV/SIV Brain invasion and neuronal dysfunction. Front. Immunol. 10, 2447. 10.3389/fimmu.2019.02447", "ArticleIdList": ["10.3389/fimmu.2019.02447", "PMC6803470", "31681324"]}, {"Citation": "Levi M., Coppens M. (2021). Vascular mechanisms and manifestations of COVID-19. Lancet. Respir. Med. 9, 551\u2013553. 10.1016/S2213-2600(21)00221-6", "ArticleIdList": ["10.1016/S2213-2600(21)00221-6", "PMC8128673", "34015324"]}, {"Citation": "Li F., Li J., Wang P.-H., Yang N., Huang J., Ou J., et al. (2021). SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling. Biochim. Biophys. Acta. Mol. Basis Dis. 1867, 166260. 10.1016/j.bbadis.2021.166260", "ArticleIdList": ["10.1016/j.bbadis.2021.166260", "PMC8390448", "34461258"]}, {"Citation": "Magro C., Mulvey J. J., Berlin D., Nuovo G., Salvatore S., Harp J., et al. (2020). Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl. Res. 220, 1\u201313. 10.1016/j.trsl.2020.04.007", "ArticleIdList": ["10.1016/j.trsl.2020.04.007", "PMC7158248", "32299776"]}, {"Citation": "Mandal A. K. J., Kho J., Ioannou A., van den Abbeele K., Missouris C. G. (2021). Covid-19 and in situ pulmonary artery thrombosis. Respir. Med. 176, 106176. 10.1016/j.rmed.2020.106176", "ArticleIdList": ["10.1016/j.rmed.2020.106176", "PMC7529605", "33092932"]}, {"Citation": "Marchetti M. (2020). COVID-19-driven endothelial damage: Complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure. Ann. Hematol. 99, 1701\u20131707. 10.1007/s00277-020-04138-8", "ArticleIdList": ["10.1007/s00277-020-04138-8", "PMC7312112", "32583086"]}, {"Citation": "Martinez J., Ferber A., Bach T. L., Yaen C. H. (2001). Interaction of fibrin with VE-cadherin. Ann. N. Y. Acad. Sci. 936, 386\u2013405. 10.1111/j.1749-6632.2001.tb03524.x", "ArticleIdList": ["10.1111/j.1749-6632.2001.tb03524.x", "11460494"]}, {"Citation": "McCracken I. R., Saginc G., He L., Huseynov A., Daniels A., Fletcher S., et al. (2021). Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells. Circulation 143, 865\u2013868. 10.1161/CIRCULATIONAHA.120.052824", "ArticleIdList": ["10.1161/CIRCULATIONAHA.120.052824", "PMC7899720", "33405941"]}, {"Citation": "McLaughlin V. v., Shah S. J., Souza R., Humbert M. (2015). Management of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 65, 1976\u20131997. 10.1016/j.jacc.2015.03.540", "ArticleIdList": ["10.1016/j.jacc.2015.03.540", "25953750"]}, {"Citation": "Morales Cano D., Mondejar Parre\u00f1o G., Medrano Garcia S., Barreira B., Callejo M., Esquivel Ruiz S., et al. (2019). Effects of schistosoma mansoni and HIV-1 Co-exposure on pulmonary vascular pathology in Proceedings of the American Thoracic Society International Conference Meetings Abstracts American Thoracic Society International Conference Meetings Abstracts, San Fransisco, California, May 13-18-2022."}, {"Citation": "Morris T. A., Marsh J. J., Chiles P. G., Auger W. R., Fedullo P. F., Woods V. L. (2006). Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Am. J. Respir. Crit. Care Med. 173, 1270\u20131275. 10.1164/RCCM.200506-916OC", "ArticleIdList": ["10.1164/RCCM.200506-916OC", "PMC2662971", "16514114"]}, {"Citation": "Morse J. H., Barst R. J., Itescu S., Flaster E. R., Sinha G., Zhang Y., et al. (1996). Primary pulmonary hypertension in HIV infection: An outcome determined by particular HLA class II alleles. Am. J. Respir. Crit. Care Med. 153, 1299\u20131301. 10.1164/ajrccm.153.4.8616557", "ArticleIdList": ["10.1164/ajrccm.153.4.8616557", "8616557"]}, {"Citation": "Mueller-Peltzer K., Krauss T., Benndorf M., Lang C. N., Bamberg F., Bode C., et al. (2020). Pulmonary artery thrombi are co-located with opacifications in SARS-CoV2 induced ARDS. Respir. Med. 172, 106135. 10.1016/j.rmed.2020.106135", "ArticleIdList": ["10.1016/j.rmed.2020.106135", "PMC7483034", "32947171"]}, {"Citation": "Muus C., Luecken M. D., Eraslan G., Sikkema L., Waghray A., Heimberg G., et al. (2021). Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Nat. Med. 27, 546\u2013559. 10.1038/s41591-020-01227-z", "ArticleIdList": ["10.1038/s41591-020-01227-z", "PMC9469728", "33654293"]}, {"Citation": "Norderfeldt J., Liliequist A., Frostell C., Adding C., Agvald P., Eriksson M., et al. (2021). Acute pulmonary hypertension and short-term outcomes in severe Covid-19 patients needing intensive care. Acta Anaesthesiol. Scand. 65, 761\u2013769. 10.1111/aas.13819", "ArticleIdList": ["10.1111/aas.13819", "PMC8250592", "33728633"]}, {"Citation": "Noris M., Benigni A., Remuzzi G. (2020). The case of complement activation in COVID-19 multiorgan impact. Kidney Int. 98, 314\u2013322. 10.1016/j.kint.2020.05.013", "ArticleIdList": ["10.1016/j.kint.2020.05.013", "PMC7246017", "32461141"]}, {"Citation": "Oktaviono Y. H., Mulia E. P. B., Luke K., Nugraha D., Maghfirah I., Subagjo A. (2021). Right ventricular dysfunction and pulmonary hypertension in COVID-19: A meta-analysis of prevalence and its association with clinical outcome. Arch. Med. Sci. 18, 1169\u20131180. 10.5114/AOMS/136342", "ArticleIdList": ["10.5114/AOMS/136342", "PMC9479723", "36160328"]}, {"Citation": "Olsson K. M., Delcroix M., Ghofrani H. A., Tiede H., Huscher D., Speich R., et al. (2014). Anticoagulation and survival in pulmonary arterial hypertension: Results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA). Circulation 129, 57\u201365. 10.1161/CIRCULATIONAHA.113.004526", "ArticleIdList": ["10.1161/CIRCULATIONAHA.113.004526", "24081973"]}, {"Citation": "Pagnesi M., Baldetti L., Beneduce A., Calvo F., Gramegna M., Pazzanese V., et al. (2020). Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19. Heart 106, 1324\u20131331. 10.1136/heartjnl-2020-317355", "ArticleIdList": ["10.1136/heartjnl-2020-317355", "PMC7476272", "32675217"]}, {"Citation": "Pang J., Xu F., Aondio G., Li Y., Fumagalli A., Lu M., et al. (2021). Efficacy and tolerability of bevacizumab in patients with severe Covid-19. Nat. Commun. 12, 814. 10.1038/s41467-021-21085-8", "ArticleIdList": ["10.1038/s41467-021-21085-8", "PMC7864918", "33547300"]}, {"Citation": "Petrey A. C., Qeadan F., Middleton E. A., Pinchuk I. v., Campbell R. A., Beswick E. J. (2021). Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex. J. Leukoc. Biol. 109, 55\u201366. 10.1002/JLB.3COVA0820-410RRR", "ArticleIdList": ["10.1002/JLB.3COVA0820-410RRR", "PMC7902354", "32930456"]}, {"Citation": "Phetsouphanh C., Darley D. R., Wilson D. B., Howe A., Munier C. M. L., Patel S. K., et al. (2022). Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210\u2013216. 10.1038/s41590-021-01113-x", "ArticleIdList": ["10.1038/s41590-021-01113-x", "35027728"]}, {"Citation": "Potus F., Mai V., Lebret M., Malenfant S., Breton-Gagnon E., Lajoie A. C., et al. (2020). Novel insights on the pulmonary vascular consequences of COVID-19. Am. J. Physiol. Lung Cell. Mol. Physiol. 319, L277\u2013L288. 10.1152/ajplung.00195.2020", "ArticleIdList": ["10.1152/ajplung.00195.2020", "PMC7414237", "32551862"]}, {"Citation": "Poudel A., Poudel Y., Adhikari A., Aryal B. B., Dangol D., Bajracharya T., et al. (2021). D-Dimer as a biomarker for assessment of COVID-19 prognosis: D-Dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PLoS One 16, e0256744. 10.1371/journal.pone.0256744", "ArticleIdList": ["10.1371/journal.pone.0256744", "PMC8389366", "34437642"]}, {"Citation": "Rafikova O., al Ghouleh I., Rafikov R. (2019). Focus on early events: Pathogenesis of pulmonary arterial hypertension development. Antioxid. Redox Signal. 31, 933\u2013953. 10.1089/ars.2018.7673", "ArticleIdList": ["10.1089/ars.2018.7673", "PMC6765063", "31169021"]}, {"Citation": "Raval A., Edwards N., Kant R., Verma V. (2021). COVID-19 as a primary cause of pulmonary arterial hypertension. Chest 160, A2198. 10.1016/J.CHEST.2021.07.1939", "ArticleIdList": ["10.1016/J.CHEST.2021.07.1939"]}, {"Citation": "Ren Y., Wang A., Fang Y., Shu T., Wu D., Wang C., et al. (2021). SARS-CoV-2 membrane glycoprotein M triggers apoptosis with the assistance of nucleocapsid protein N in cells. Front. Cell. Infect. Microbiol. 11, 706252. 10.3389/fcimb.2021.706252", "ArticleIdList": ["10.3389/fcimb.2021.706252", "PMC8425412", "34513728"]}, {"Citation": "Roncati L., Ligabue G., Fabbiani L., Malagoli C., Gallo G., Lusenti B., et al. (2020). Type 3 hypersensitivity in COVID-19 vasculitis. Clin. Immunol. 217, 108487. 10.1016/j.clim.2020.108487", "ArticleIdList": ["10.1016/j.clim.2020.108487", "PMC7256503", "32479986"]}, {"Citation": "Roncon L., Zuin M., Barco S., Valerio L., Zuliani G., Zonzin P., et al. (2020). Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis. Eur. J. Intern. Med. 82, 29\u201337. 10.1016/j.ejim.2020.09.006", "ArticleIdList": ["10.1016/j.ejim.2020.09.006", "PMC7498252", "32958372"]}, {"Citation": "Rossi R., Coppi F., Monopoli D. E., Sgura F. A., Arrotti S., Boriani G. (2022). Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors. Cardiol. J. 29, 163\u2013165. 10.5603/CJ.a2021.0159", "ArticleIdList": ["10.5603/CJ.a2021.0159", "PMC8890407", "34897638"]}, {"Citation": "Sajal D., Mudalsha R., Tinu L., Ranganath T. G., Dibakar S. (2021). Lung perfusion scintigraphy early after COVID-19: A single-center retrospective study. J. Nucl. Med. Technol. 49, 320\u2013323. 10.2967/jnmt.121.262440", "ArticleIdList": ["10.2967/jnmt.121.262440", "PMC8712630", "34330803"]}, {"Citation": "Sakao S., Hao H., Tanabe N., Kasahara Y., Kurosu K., Tatsumi K. (2011). Endothelial-like cells in chronic thromboembolic pulmonary hypertension: Crosstalk with myofibroblast-like cells. Respir. Res. 12, 109. 10.1186/1465-9921-12-109", "ArticleIdList": ["10.1186/1465-9921-12-109", "PMC3170233", "21854648"]}, {"Citation": "Salcin S., Fontem F. (2021). Recurrent SARS-CoV-2 infection resulting in acute respiratory distress syndrome and development of pulmonary hypertension: A case report. Respir. Med. Case Rep. 33, 101314. 10.1016/j.rmcr.2020.101314", "ArticleIdList": ["10.1016/j.rmcr.2020.101314", "PMC7718582", "33312856"]}, {"Citation": "Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., et al. (2020). Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. U. S. A. 117, 11727\u201311734. 10.1073/pnas.2003138117", "ArticleIdList": ["10.1073/pnas.2003138117", "PMC7260975", "32376634"]}, {"Citation": "Shi H., Wang W., Yin J., Ouyang Y., Pang L., Feng Y., et al. (2020). The inhibition of IL-2/IL-2R gives rise to CD8(+) T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia. Cell. Death Dis. 11, 429. 10.1038/s41419-020-2636-4", "ArticleIdList": ["10.1038/s41419-020-2636-4", "PMC7276960", "32513989"]}, {"Citation": "Silva D. M. da, Gon\u00e7ales J. P., Silva J\u00fanior J. V. J., Lopes T. R. R., Bezerra L. A., Barros de Lorena V. M., et al. (2021). Evaluation of IL-2, IL-4, IL-6, IL-10, TNF-\u03b1, and IFN-\u03b3 cytokines in HIV/HHV-8 coinfection. J. Med. Virol. 93, 4033\u20134037. 10.1002/jmv.26516", "ArticleIdList": ["10.1002/jmv.26516", "32926412"]}, {"Citation": "Simonneau G., Montani D., Celermajer D. S., Denton C. P., Gatzoulis M. A., Krowka M., et al. (2019). Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur. Respir. J. 53, 1801913. 10.1183/13993003.01913-2018", "ArticleIdList": ["10.1183/13993003.01913-2018", "PMC6351336", "30545968"]}, {"Citation": "Spikes L., Dalvi P., Tawfik O., Gu H., Voelkel N. F., Cheney P., et al. (2012). Enhanced pulmonary arteriopathy in simian immunodeficiency virus-infected macaques exposed to morphine. Am. J. Respir. Crit. Care Med. 185, 1235\u20131243. 10.1164/rccm.201110-1909OC", "ArticleIdList": ["10.1164/rccm.201110-1909OC", "PMC3373069", "22447963"]}, {"Citation": "Stenmark K. R., Frid M. G., Gerasimovskaya E., Zhang H., McCarthy M. K., Thurman J. M., et al. (2021). Mechanisms of SARS-CoV-2-induced lung vascular disease: Potential role of complement. Pulm. Circ. 11, 20458940211015799. 10.1177/20458940211015799", "ArticleIdList": ["10.1177/20458940211015799", "PMC8138299", "34046161"]}, {"Citation": "Suntharalingam J., Goldsmith K., van Marion V., Long L., Treacy C. M., Dudbridge F., et al. (2008). Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 31, 736\u2013741. 10.1183/09031936.00055107", "ArticleIdList": ["10.1183/09031936.00055107", "18057060"]}, {"Citation": "Suresh S. J., Suzuki Y. J. (2020). SARS-CoV-2 spike protein and lung vascular cells. JoR. 20211 (1), 4040\u20134848. 10.3390/JOR1010004", "ArticleIdList": ["10.3390/JOR1010004"]}, {"Citation": "Suzuki Y. J., Nikolaienko S. I., Dibrova V. A., Dibrova Y. v., Vasylyk V. M., Novikov M. Y., et al. (2021). SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells. Vasc. Pharmacol. 137, 106823. 10.1016/j.vph.2020.106823", "ArticleIdList": ["10.1016/j.vph.2020.106823", "PMC7680014", "33232769"]}, {"Citation": "Swenson K. E., Ruoss S. J., Swenson E. R. (2021). The pathophysiology and dangers of silent hypoxemia in COVID-19 lung injury. Ann. Am. Thorac. Soc. 18, 1098\u20131105. 10.1513/AnnalsATS.202011-1376CME", "ArticleIdList": ["10.1513/AnnalsATS.202011-1376CME", "PMC8328372", "33621159"]}, {"Citation": "Tai W., He L., Zhang X., Pu J., Voronin D., Jiang S., et al. (2020). Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell. Mol. Immunol. 17, 613\u2013620. 10.1038/s41423-020-0400-4", "ArticleIdList": ["10.1038/s41423-020-0400-4", "PMC7091888", "32203189"]}, {"Citation": "Taniguchi-Ponciano K., Vadillo E., Mayani H., Gonzalez-Bonilla C. R., Torres J., Majluf A., et al. (2021). Increased expression of hypoxia-induced factor 1\u03b1 mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients. Ann. Med. 53, 197\u2013207. 10.1080/07853890.2020.1858234", "ArticleIdList": ["10.1080/07853890.2020.1858234", "PMC7784832", "33345622"]}, {"Citation": "Tardif J. C., Bouabdallaoui N., L\u2019Allier P. L., Gaudet D., Shah B., Pillinger M. H., et al. (2021). Colchicine for community-treated patients with COVID-19 (COLCORONA): A phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. Lancet. Respir. Med. 9, 924\u2013932. 10.1016/S2213-2600(21)00222-8", "ArticleIdList": ["10.1016/S2213-2600(21)00222-8", "PMC8159193", "34051877"]}, {"Citation": "Taylor C. T., Colgan S. P. (2017). Regulation of immunity and inflammation by hypoxia in immunological niches. Nat. Rev. Immunol. 17, 774\u2013785. 10.1038/nri.2017.103", "ArticleIdList": ["10.1038/nri.2017.103", "PMC5799081", "28972206"]}, {"Citation": "Thenappan T., Shah S. J., Rich S., Tian L., Archer S. L., Gomberg-Maitland M. (2010). Survival in pulmonary arterial hypertension: A reappraisal of the NIH risk stratification equation. Eur. Respir. J. 35, 1079\u20131087. 10.1183/09031936.00072709", "ArticleIdList": ["10.1183/09031936.00072709", "PMC8782564", "20032020"]}, {"Citation": "Thompson W. D., Smith E. B., Stirk C. M., Marshall F. I., Stout A. J., Kocchar A. (1992). Angiogenic activity of fibrin degradation products is located in fibrin fragment E. J. Pathol. 168, 47\u201353. 10.1002/path.1711680109", "ArticleIdList": ["10.1002/path.1711680109", "1280677"]}, {"Citation": "Tobin M. J., Laghi F., Jubran A. (2020). Why COVID-19 silent hypoxemia is baffling to physicians. Am. J. Respir. Crit. Care Med. 202, 356\u2013360. 10.1164/rccm.202006-2157CP", "ArticleIdList": ["10.1164/rccm.202006-2157CP", "PMC7397783", "32539537"]}, {"Citation": "Townsend L., Fogarty H., Dyer A., Martin-Loeches I., Bannan C., Nadarajan P., et al. (2021). Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J. Thromb. Haemost. 19, 1064\u20131070. 10.1111/jth.15267", "ArticleIdList": ["10.1111/jth.15267", "PMC8013297", "33587810"]}, {"Citation": "Tudoran C., Tudoran M., Lazureanu V. E., Marinescu A. R., Pop G. N., Pescariu A. S., et al. (2021). Evidence of pulmonary hypertension after SARS-CoV-2 infection in subjects without previous significant cardiovascular pathology. J. Clin. Med. 10, 199. 10.3390/jcm10020199", "ArticleIdList": ["10.3390/jcm10020199", "PMC7827420", "33430492"]}, {"Citation": "van Dongen C. M., Janssen M. T., van der Horst R. P., van Kraaij D. J., Peeters R. H., van den Toorn L. M., et al. (2020). Unusually rapid development of pulmonary hypertension and right ventricular failure after COVID-19 pneumonia. Eur. J. Case Rep. Intern. Med. 7, 001784. 10.12890/2020_001784", "ArticleIdList": ["10.12890/2020_001784", "PMC7350962", "32665939"]}, {"Citation": "Vlachou M., Drebes A., Candilio L., Weeraman D., Mir N., Murch N., et al. (2021). Pulmonary thrombosis in covid-19: Before, during and after hospital admission. J. Thromb. Thrombolysis 51, 978\u2013984. 10.1007/s11239-020-02370-7", "ArticleIdList": ["10.1007/s11239-020-02370-7", "PMC7775738", "33386559"]}, {"Citation": "Walls A. C., Park Y.-J., Tortorici M. A., Wall A., McGuire A. T., Veesler D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 181, 281\u2013292. e6. 10.1016/j.cell.2020.02.058", "ArticleIdList": ["10.1016/j.cell.2020.02.058", "PMC7102599", "32155444"]}, {"Citation": "Wang L., Wang Q., Davis P. B., Volkow N. D., Xu R. (2022). Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021. World Psychiatry. 21, 124\u2013132. 10.1002/wps.20921", "ArticleIdList": ["10.1002/wps.20921", "PMC8661963", "34612005"]}, {"Citation": "Wang Q. Q., Kaelber D. C., Xu R., Volkow N. D. (2021). COVID-19 risk and outcomes in patients with substance use disorders: Analyses from electronic health records in the United States. Mol. Psychiatry 26, 30\u201339. 10.1038/s41380-020-00880-7", "ArticleIdList": ["10.1038/s41380-020-00880-7", "PMC7488216", "32929211"]}, {"Citation": "Wang X., Tu Y., Huang B., Li Y., Li Y., Zhang S., et al. (2020). Pulmonary vascular endothelial injury and acute pulmonary hypertension caused by COVID-19: The fundamental cause of refractory hypoxemia? Cardiovasc. Diagn. Ther. 10, 892\u2013897. 10.21037/cdt-20-429", "ArticleIdList": ["10.21037/cdt-20-429", "PMC7487391", "32968645"]}, {"Citation": "Ward P. A., Fattahi F., Bosmann M. (2016). New insights into molecular mechanisms of immune complex-induced injury in lung. Front. Immunol. 7, 86. 10.3389/fimmu.2016.00086", "ArticleIdList": ["10.3389/fimmu.2016.00086", "PMC4783387", "27014266"]}, {"Citation": "Wichmann D., Sperhake J.-P., L\u00fctgehetmann M., Steurer S., Edler C., Heinemann A., et al. (2020). Autopsy findings and venous thromboembolism in patients with COVID-19: A prospective cohort study. Ann. Intern. Med. 173, 268\u2013277. 10.7326/M20-2003", "ArticleIdList": ["10.7326/M20-2003", "PMC7240772", "32374815"]}, {"Citation": "Willems L. H., Nagy M., ten Cate H., Spronk H. M. H., Groh L. A., Leentjens J., et al. (2022). Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. Thromb. Res. 209, 106\u2013114. 10.1016/j.thromres.2021.11.027", "ArticleIdList": ["10.1016/j.thromres.2021.11.027", "PMC8642246", "34922160"]}, {"Citation": "\nWorld Health Organization (2022). (COVID-19) dashboard | WHO coronavirus (COVID-19) dashboard with vaccination data. Available at: https://covid19.who.int/\n(Accessed May 22, 2022)."}, {"Citation": "Xi X., Guo Y., Zhu M., Wei Y., Li G., Du B., et al. (2021). Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling. Virol. J. 18, 12. 10.1186/s12985-020-01478-9", "ArticleIdList": ["10.1186/s12985-020-01478-9", "PMC7788192", "33413449"]}, {"Citation": "Xing J., Wang M., Hong J., Gao Y., Liu Y., Gu H., et al. (2019). TRPM7 channel inhibition exacerbates pulmonary arterial hypertension through MEK/ERK pathway. Aging 11, 4050\u20134065. 10.18632/aging.102036", "ArticleIdList": ["10.18632/aging.102036", "PMC6629001", "31219801"]}, {"Citation": "Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., et al. (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet. Respir. Med. 8, 420\u2013422. 10.1016/S2213-2600(20)30076-X", "ArticleIdList": ["10.1016/S2213-2600(20)30076-X", "PMC7164771", "32085846"]}, {"Citation": "Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. (2020). Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444\u20131448. 10.1126/science.abb2762", "ArticleIdList": ["10.1126/science.abb2762", "PMC7164635", "32132184"]}, {"Citation": "Yi E. S., Kim H., Ahn H., Strother J., Morris T., Masliah E., et al. (2000). Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. Am. J. Respir. Crit. Care Med. 162, 1577\u20131586. 10.1164/ajrccm.162.4.9912131", "ArticleIdList": ["10.1164/ajrccm.162.4.9912131", "11029379"]}, {"Citation": "Yoo J.-S., Sasaki M., Cho S. X., Kasuga Y., Zhu B., Ouda R., et al. (2021). SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis. Nat. Commun. 12, 6602. 10.1038/s41467-021-26910-8", "ArticleIdList": ["10.1038/s41467-021-26910-8", "PMC8594428", "34782627"]}, {"Citation": "Zabini D., Nagaraj C., Stacher E., Lang I. M., Nierlich P., Klepetko W., et al. (2012). Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction. PLoS One 7, e43793. 10.1371/journal.pone.0043793", "ArticleIdList": ["10.1371/journal.pone.0043793", "PMC3423379", "22916307"]}, {"Citation": "Zhan H., Chen H., Liu C., Cheng L., Yan S., Li H., et al. (2021). Diagnostic value of D-dimer in COVID-19: A meta-analysis and meta-regression. Clin. Appl. Thromb. Hemost. 27, 10760296211010976. 10.1177/10760296211010976", "ArticleIdList": ["10.1177/10760296211010976", "PMC8114749", "33926262"]}, {"Citation": "Zhang R., Wu Y., Zhao M., Liu C., Zhou L., Shen S., et al. (2009). Role of HIF-1alpha in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 297, L631\u2013L640. 10.1152/ajplung.90415.2008", "ArticleIdList": ["10.1152/ajplung.90415.2008", "19592460"]}, {"Citation": "Zhang Y., Chen Y., Li Y., Huang F., Luo B., Yuan Y., et al. (2021). The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-\u0399. Proc. Natl. Acad. Sci. U. S. A. 118, e2024202118. 10.1073/pnas.2024202118", "ArticleIdList": ["10.1073/pnas.2024202118", "PMC8201919", "34021074"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "20"}, {"Year": "2022", "Month": "11", "Day": "25"}, {"Year": "2023", "Month": "1", "Day": "5", "Hour": "2", "Minute": "29"}, {"Year": "2023", "Month": "1", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "6", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "12", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["36601347", "PMC9806360", "10.3389/fphys.2022.1023758", "1023758"]}}], "PubmedBookArticle": []}